Difference between revisions of "Team:Bielefeld-CeBiTec/Project/toolbox/fusing"

Line 32: Line 32:
 
As proof of concept, we work on enhanced stability of a protein polymer. This networks  
 
As proof of concept, we work on enhanced stability of a protein polymer. This networks  
 
can be applied for different applications like modern biomaterials in medicine and industry  
 
can be applied for different applications like modern biomaterials in medicine and industry  
−
(Rnjak-Kovacina&nbsp;<i>et&nbsp;al.</i>,&nbsp;2011). The amino acids N<sup>ε</sup>&#x2011;L&#x2011;cysteinyl&#x2011;L&#x2011;lysine (CL)  
+
(Rnjak-Kovacina&nbsp;<i>et&nbsp;al.</i>,&nbsp;2011). The amino acids <i>N</i><sup>ε</sup>&#x2011;L&#x2011;cysteinyl&#x2011;L&#x2011;lysine (CL)  
−
and N<sup>γ</sup>&#x2011;2&#x2011;cyanobenzothiazol&#x2011;6&#x2011;yl&#x2011;L&#x2011;asparagine (CBT&#x2011;asparagine)  
+
and <i>N</i><sup>γ</sup>&#x2011;2&#x2011;cyanobenzothiazol&#x2011;6&#x2011;yl&#x2011;L&#x2011;asparagine (CBT&#x2011;asparagine)  
 
comprise key parts of this tool. Both amino acids can bind specificly to each other resulting in the formation  
 
comprise key parts of this tool. Both amino acids can bind specificly to each other resulting in the formation  
 
of a covalent bond between their side chains. We plan to use this covalent bond to increase the stability of  
 
of a covalent bond between their side chains. We plan to use this covalent bond to increase the stability of  
Line 79: Line 79:
 
</p>
 
</p>
 
</div>
 
</div>
−
<h3>N<sup>ε</sup>-L-cysteinyl-L-lysine</h3>
+
<h3><i>N</i><sup>ε</sup>-L-cysteinyl-L-lysine</h3>
 
<article>
 
<article>
 
We synthesized CL in our lab and provide the community with a validated protocol. Currently, we are  
 
We synthesized CL in our lab and provide the community with a validated protocol. Currently, we are  
Line 96: Line 96:
 
specific binding between the CL and the CBT&#x2011;asparagine.  
 
specific binding between the CL and the CBT&#x2011;asparagine.  
 
<ul>
 
<ul>
−
<li>Name: N<sup>ε</sup>-L-cysteinyl-L-lysine</li>
+
<li>Name: <i>N</i><sup>ε</sup>-L-cysteinyl-L-lysine</li>
 
<li>Short: CL
 
<li>Short: CL
 
<li>Molecular Weight: 249.33 g mol<sup>-1</sup></li>
 
<li>Molecular Weight: 249.33 g mol<sup>-1</sup></li>
Line 114: Line 114:
 
</div>
 
</div>
  
−
<h3>N<sup>γ</sup>-2-cyanobenzothiazol-6-yl-L-asparagine</h3>
+
<h3><i>N</i><sup>γ</sup>-2-cyanobenzothiazol-6-yl-L-asparagine</h3>
 
<!-- Zwei Divs nebeneinander - Hier kann man Bilder oder articles einfuegen -->
 
<!-- Zwei Divs nebeneinander - Hier kann man Bilder oder articles einfuegen -->
 
<div class="contentline">
 
<div class="contentline">
Line 130: Line 130:
 
group of the side chain of L-asparagine. The cyano group of the CBT enables the specific binding of the CBT&#x2011;asparagine to 1,2-aminothiols.
 
group of the side chain of L-asparagine. The cyano group of the CBT enables the specific binding of the CBT&#x2011;asparagine to 1,2-aminothiols.
 
<ul>
 
<ul>
−
<li>Name: N<sup>γ</sup>&#x2011;2&#x2011;cyanobenzothiazol&#x2011;6&#x2011;yl&#x2011;L&#x2011;asparagine</li>
+
<li>Name: <i>N</i><sup>γ</sup>&#x2011;2&#x2011;cyanobenzothiazol&#x2011;6&#x2011;yl&#x2011;L&#x2011;asparagine</li>
 
<li>Short: CBT&#x2011;asparagine
 
<li>Short: CBT&#x2011;asparagine
 
<li>Molecular Weight: 290.30 g mol<sup>-1</sup></li>
 
<li>Molecular Weight: 290.30 g mol<sup>-1</sup></li>

Revision as of 15:16, 1 November 2017

Fusing

Short summary

Fusing proteins is normally limited to the C‑ or N‑terminus of a protein. The incorporation of non-canonical amino acids that could be fused to each other or to surfaces enables several additional applications. This tool facilitates immobilization of proteins and improved stability of protein polymer networks. Furthermore, they lead to enhanced efficiency of pathways by combining enzymes of one pathway or for any other system where colocalization is beneficial.
As proof of concept, we work on enhanced stability of a protein polymer. This networks can be applied for different applications like modern biomaterials in medicine and industry (Rnjak-Kovacina et al., 2011). The amino acids Nε‑L‑cysteinyl‑L‑lysine (CL) and Nγ‑2‑cyanobenzothiazol‑6‑yl‑L‑asparagine (CBT‑asparagine) comprise key parts of this tool. Both amino acids can bind specificly to each other resulting in the formation of a covalent bond between their side chains. We plan to use this covalent bond to increase the stability of silk elastin like proteins (SELPs). The strengthened polymer network would be a perfect material to produce biological wound bindings which are very thin and they would be able to interact with the natural tissue matrix (Boateng et al., 2008).

Terminus independent fusion proteins

While terminus dependent binding systems for proteins are already in use, there are only a few systems for terminus independent binding systems. We want to expand the number of those systems. Our aim is to incorporate two non-canonical amino acids, which are able to build a specific bond to each other. According to the synthesis of D-luciferin for the firefly luciferase of Photinus pyralis, we decided to use the specific binding of 1,2‑aminothiols and the cyano group of cyanobenzothiazole (CBT). Figure 1 shows the biosynthesis of luciferin and the mechanism of the binding reaction of 1,2‑aminothiol and CBT.

Figure 1: Reaction of the 1,2‑aminothiol of cysteine and CBT to luciferin (Liang et al., 2010).

By synthesis of amino acids with side chains containing CBT and a 1,2‑aminothiol, polypeptides binding to each other should be produced. These amino acids are CL and CBT‑asparagine. The binding mechanism of both amino acids are shown in figure 2.

Figure 2: Specific binding reaction of CL and CBT-asparagine.

Nε-L-cysteinyl-L-lysine

We synthesized CL in our lab and provide the community with a validated protocol. Currently, we are trying to synthesize CBT‑asparagine. Details of our synthesis protocol are described in the method section.
CL is an amino acid consisting of cysteine and lysine. The cysteine was coupled to the side chain of lysine so that CL contains a free 1,2-aminothiol group (Nguyen et al., 2011). This is an important characteristic for the specific binding between the CL and the CBT‑asparagine.
  • Name: Nε-L-cysteinyl-L-lysine
  • Short: CL
  • Molecular Weight: 249.33 g mol-1
  • Storage: -20 – 4 °C
  • Function: Terminus independent binding system

Figure 3: Structure of CL.

Nγ-2-cyanobenzothiazol-6-yl-L-asparagine

Figure 4: Structure of CBT‑asparagine.

CBT‑asparagine is a completely novel amino acid, which we are synthesizing on our own. The synthesis is based on coupling the amino group of 6-Amino-CBT to the carboxyl group of the side chain of L-asparagine. The cyano group of the CBT enables the specific binding of the CBT‑asparagine to 1,2-aminothiols.
  • Name: Nγ‑2‑cyanobenzothiazol‑6‑yl‑L‑asparagine
  • Short: CBT‑asparagine
  • Molecular Weight: 290.30 g mol-1
  • Storage: -20 – 4 °C
  • Function: Terminus independent binding system

Silk Elastin like Proteins

This specific binding can improve the stability of SELPs. These are linear polypeptides with repeats of silk and elastin consensus sequences. They show brought application and possibilities in medicine, tissue engineering and industry (Rnjak-Kovacina et al., 2011). The silk consensus sequence is GAGAGS and the elastin consensus sequence is VPAVG. The consensus sequences can interact with each other and are able to form non-covalent hydrogen bonds. This results in a polymer network based on hydrogen bonds with a β-sheet structure. Figure 5 shows the schematic structure of a SELP polymer network.

Figure 5: Schematic structure of a SELP polymer network.
Silk consensus sequences are shown in green, elastin consensus sequences are red and the blue lines show the hydrogen bonds of the consensus sequences.

According to the work of Collins et al. (2013), we decided to use a sequence with nine repeats of five repeats of the silk consensus sequence and nine repeats of the elastin consensus sequence (see figure 6).

Figure 6: Schematic sequence of the SELP (Collins et al., 2013).
Silk consensus sequences are green and elastin consensus sequences are red.

By incorporation of CL and CBT‑asparagine between the silk and the elastin repeats, we receive a strengthened polymer network with covalent bonds (Figure 7).

Figure 7: Schematic structure of a SELP polymer network.

Recursive Directional Ligation by Plasmid Reconstruction (PRe-RDL)

The gene sequence for these SELPs has a high GC content and contains a high number of repeats leading to issues during synthesis. Therefore, PRe-RDL can be applied to address this challenge. PRe-RDL uses three restriction sites of a parent plasmid which contains the gene of interest (goi) and the subsequently ligation of fragments of two different restricted parent plasmids. The first step involves the restriction of a parent plasmid at the 3'-end of the goi and in the backbone. The second step is the restriction of a parent plasmid at the 5'-end of the goi and at the same position of the backbone as in the first step. The final step is the ligation of both generated fragments containing the goi. The result is a plasmid with two copies of the goi (Figure 5).

Figure 8: Scheme of the PRe-RDL according to McDaniel et al., 2010 and applied to pSB1C3 containing one elastin consensus sequence. The Pre-RDL consists out of 3 steps, two different digestions (step 1 and 2) and one ligation (step 3).

Applied to pSB1C3 containing the consensus sequences of monomers and the spacers between the BioBrick prefix and suffix shown in figure 9, it is possible to use the PRe-RDL in combination with the restriction enzymes, AcuI, BseRI, and BspEI, to build repetitive sequences of monomers.

Figure 9: Design of K2201250 and K2201251.

Step 1 serves to create a fragment containing one part of the chloramphenicol resistance (CmR) and the whole monomer consensus sequence. To do so, the plasmid has to be digested by AcuI and BspEI. The other fragments which are resulting from this step contain the other part of the CmR and each one part of the origin of replication (ori). This decreases the chance of religation of the three fragments originating from this step. For step 2, it is necessary to use BseRI and BspEI. The result of this digestion is one fragment containing one part of the CmR and the spacer between the prefix and the monomer consensus sequence and one fragment with the other part of the CmR, the ori, and the monomer consensus squence. By ligation of both fragments of step 1 and 2 containing the monomer consensus sequence (step 3) you get pSB1C3 with two repeats of the monomer consensus sequence. By repeating these steps it is possible to create repetitive sequences consisiting out of monomeric consenesus sequences. During the PRe-RDL it is possible to add codons like the amber codon using primers. After the PRe-RDL it is necessary to add a start and a stop codon.

References

Boateng, J., Matthews, K.H., Stevens, H.N.E., and Eccleston, G.M. (2008). Wound Healing Dressings and Drug Delivery Systems: A Review. J. Pharm. Sci. 97.

Collins, T., Azevedo-silva, J., Costa, A., Branca, F., Machado, R., and Casal, M. (2013). Batch production of a silk-elastin-like protein in E . coli BL21 ( DE3 ): key parameters for optimisation. Microb. Cell Fact. 12: 1–16.

Liang, G., Ren, H., and Rao, J. (2010). A biocompatible condensation reaction for controlled assembly of nanostructures in living cells. Nat. Chem. 2: 54–60.

McDaniel, J.R., Mackay, J.A., Quiroz, F.G., and Chilkoti, A. (2010). Recursive Directional Ligation by Plasmid Reconstruction allows Rapid and Seamless Cloning of Oligomeric Genes. 11: 944–952.

Nguyen, D.P., Elliott, T., Holt, M., Muir, T.W., and Chin, J.W. (2011). Genetically Encoded 1,2-Aminothiols Facilitate Rapid and Site-Specific Protein Labeling via a Bio-orthogonal Cyanobenzothiazole Condensation. J. Am. Chem. Soc. 133: 11418–11421.

Rnjak-Kovacina, J., Daamen, W.F., Pierna, M., Rodríguez-Cabello, J.C., and Weiss, A.S. (2011). Elastin Biopolymers. Compr. Biomater.: 329–346.